The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Brain-computer interface technology has long belonged to the realm of science fiction, but it’s quickly emerging as a real-world innovation with the potential to transform how we live, work and ...

Neurosurgeon and Engineer Dr. Ben Rapoport, co-founder of Precision Neuroscience, joins WIRED to answer the internet's burning questions about the emerging technology of brain implants and ...

The post Sam Altman Reportedly Developing Noninvasive Brain Interface to Rival Elon Musk’s Neuralink appeared first on Android Headlines.